Previous 10 | Next 10 |
2024-05-23 14:20:37 ET More on BioNTech, Moderna, etc. Moderna: Betting On Bird Flu Rally Is A Poor Strategy For A Value Investor The Prognosis For Pfizer Pfizer: Offsetting The LOE Cliff Crisis With 6 New Potential Blockbuster Drugs Pfizer, Moderna in talks ...
2024-05-23 12:27:13 ET Summary The Health Care sector has been stagnant while other areas of the stock market reach record highs, leaving some value opportunities in drugmakers and pharma stocks. I have a buy rating on Johnson & Johnson (JNJ) given its stable earnings growth a...
2024-05-23 10:29:02 ET More on Nvidia Why I Am Still Buying Nvidia Stock Nvidia Q1: Flawless Execution From The King (Rating Upgrade) NVIDIA Corporation (NVDA) Q1 2025 Earnings Call Transcript Biggest stock movers today: NVDA, SNOW, SMCI and more 'Jus...
2024-05-23 10:15:42 ET Summary Moderna's stock price is rising on fears of a new infectious disease outbreak, and this is reminiscent of the company's pandemic gains. Moderna and Pfizer have been in talks with the Department of Health and Human Services after a second case of avia...
2024-05-23 09:00:00 ET Summary The stock market closed at record highs in the third week of May, with the S&P 500 exceeding 40,000. The Dividend Harvesting Portfolio reached another all-time high, with an ROI of 14.44% and a forward projected dividend income of $1,496.16. ...
2024-05-22 18:09:14 ET More on Moderna, Pfizer, etc. The Prognosis For Pfizer Pfizer: Offsetting The LOE Cliff Crisis With 6 New Potential Blockbuster Drugs Aggressive Strides Forward For Moderna's Cancer Vaccine Moderna, BioNTech close with double-digit perc...
2024-05-22 17:43:22 ET Several vaccine makers closed Wednesday up with double-digit percentage gains amid a report of the first avian flu case in a human in Australia and a second case in the U.S.... Read the full article on Seeking Alpha For further details see: Moderna...
2024-05-22 17:15:03 ET BMO Capital analyst issues OUTPERFORM recommendation for PFE on May 22, 2024 03:48PM ET. The previous analyst recommendation was Outperform. PFE was trading at $29.6 at issue of the analyst recommendation. The overall analyst consensus : BUY. C...
2024-05-22 17:10:18 ET This article was first published on The Motley Fool’s U.S. website. Stocks have been a wealth-creating machine for investors over the long run. Though other asset classes have delivered a positive nominal return to patient investors, including gold, oil...
2024-05-22 17:00:09 ET Evan Seigerman from BMO Capital issued a price target of $36.00 for PFE on 2024-05-22 15:48:00. The adjusted price target was set to $36.00. At the time of the announcement, PFE was trading at $29.6. The overall price target consensus is at $57.55 ...
News, Short Squeeze, Breakout and More Instantly...
2024-07-22 05:59:00 ET Both Pfizer (NYSE: PFE) and Roche Holdings (OTC: RHHBY) rank among the world's most powerful pharmaceutical companies. Yet neither is actively competing in the all-important market for weight loss drugs, which is currently being split between the likes...
2024-07-20 10:00:00 ET On July 11, Pfizer (NYSE: PFE) made an announcement that came as a bit of a surprise to biopharma industry experts and Wall Street analysts alike. It's planning on advancing one of its early-stage weight loss programs into mid-stage trials. In due time, the mo...
2024-07-18 13:06:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...